Core Viewpoint - Zhongxing Commercial's stock increased by 5.72% to 6.65 CNY per share, with a trading volume of 188 million CNY and a turnover rate of 5.45%, resulting in a total market capitalization of 3.594 billion CNY [1] Company Overview - Zhongxing-Shenyang Commercial Building (Group) Co., Ltd. is located at 86 Taiyuan North Street, Heping District, Shenyang, Liaoning Province, established on April 25, 1997, and listed on May 8, 1997 [1] - The company's main business includes domestic general commercial trade, automobile repair, auto parts, warehousing and handling, import and export trade, parking services, commercial residential office space, site leasing, and commercial enterprise investment holding [1] - The revenue composition is 88.29% from retail and 11.71% from service fees [1] Shareholder Information - Among the top ten circulating shareholders of Zhongxing Commercial, one fund from GF Fund is notable. The GF Quantitative Multi-Factor Mixed A (005225) fund entered the top ten circulating shareholders in the third quarter, holding 4.2587 million shares, which is 0.79% of the circulating shares [2] - The estimated floating profit for this fund today is approximately 1.5331 million CNY [2] - The GF Quantitative Multi-Factor Mixed A fund was established on March 21, 2018, with a latest scale of 3.618 billion CNY, achieving a year-to-date return of 46.06% and a one-year return of 47.17% [2] Fund Manager Performance - The fund manager of GF Quantitative Multi-Factor Mixed A is Yi Wei, who has been in the position for 2 years and 147 days, with a total fund asset size of 3.818 billion CNY. The best fund return during his tenure is 63.1%, while the worst is -1.88% [3] - Another fund manager, Li Yuxin, has been in the role for 2 years and 38 days, managing a fund asset size of 3.793 billion CNY, with the best return of 88.35% and the worst return of -1.88% during his tenure [3][6] Fund Holdings - The GF Smart Selection Start Mixed A (023761) fund holds 54,600 shares of Zhongxing Commercial, accounting for 0.78% of the fund's net value, ranking as the sixth-largest holding [4] - The estimated floating profit for this fund today is approximately 19,700 CNY [4] - The GF Smart Selection Start Mixed A fund was established on June 18, 2025, with a latest scale of 22.3787 million CNY and a return of 20.25% since inception [5]

Group 1 - The core point of the news is that Dali Long's stock price increased by 5.15% to 15.51 CNY per share, with a trading volume of 110 million CNY and a turnover rate of 4.65%, resulting in a total market capitalization of 3.087 billion CNY [1] - Dali Long Packaging Machinery Co., Ltd. is located in Huangpu District, Guangzhou, Guangdong Province, and was established on December 18, 1998. The company was listed on January 30, 2008, and its main business involves the research, production, and sales of liquid automation packaging machinery, as well as contract manufacturing of beverages and daily chemical liquids [1] - The revenue composition of Dali Long's main business includes 93.85% from liquid packaging machinery and automation equipment, 6.05% from contract manufacturing, and 0.10% from other sources [1] Group 2 - According to data from the top ten circulating shareholders of Dali Long, a fund under GF Fund ranks among the top shareholders. The GF Quantitative Multi-Factor Mixed A Fund (005225) entered the top ten circulating shareholders in the third quarter, holding 1.1305 million shares, which accounts for 0.72% of the circulating shares. The estimated floating profit today is approximately 859,200 CNY [2] - The GF Quantitative Multi-Factor Mixed A Fund (005225) was established on March 21, 2018, with a latest scale of 3.618 billion CNY. Year-to-date returns are 45.5%, ranking 978 out of 8130 in its category; the one-year return is 48.83%, ranking 871 out of 8054; and since inception, the return is 123.32% [2] Group 3 - The fund managers of GF Quantitative Multi-Factor Mixed A Fund are Yi Wei and Li Yuxin. As of the report, Yi Wei has a cumulative tenure of 2 years and 146 days, with a total fund asset size of 3.818 billion CNY, achieving a best fund return of 63.85% and a worst fund return of -1.66% during his tenure [3] - Li Yuxin has a cumulative tenure of 2 years and 37 days, with a total fund asset size of 3.793 billion CNY, achieving a best fund return of 86.39% and a worst fund return of -1.43% during his tenure [3]

数据显示，广发基金旗下1只基金位居中光防雷十大流通股东。广发量化多因子混合A（005225）三季 度新进十大流通股东，持有股数88.46万股，占流通股的比例为0.28%。根据测算，今日浮亏损失约57.5 万元。 广发量化多因子混合A（005225）成立日期2018年3月21日，最新规模36.18亿。今年以来收益46.17%， 同类排名840/8134；近一年收益48.64%，同类排名755/8056；成立以来收益124.34%。 广发量化多因子混合A（005225）基金经理为易威、李育鑫。 11月26日，中光防雷跌5.01%，截至发稿，报12.33元/股，成交2.17亿元，换手率5.54%，总市值40.20亿 元。 资料显示，四川中光防雷科技股份有限公司位于四川省成都高新区西部园区天宇路19号，成立日期2004 年2月18日，上市日期2015年5月13日，公司主营业务涉及防雷产品的研发、生产和销售,防雷工程的设 计和安装,提供防雷产品和防雷工程一体化的整体解决方案。铁路行业防雷领域的业务。主营业务收入 构成为：防雷系列产品68.02%，非防雷产品27.30%，防雷工程及服务4.68%。 从中光防雷十大流通股东 ...

11月24日，恒信东方涨5.43%，截至发稿，报5.82元/股，成交1.31亿元，换手率3.86%，总市值35.20亿 元。 资料显示，恒信东方文化股份有限公司位于北京市海淀区大牛房二环路19号院中关村AI北纬社区D3- 305，成立日期2001年11月3日，上市日期2010年5月20日，公司主营业务涉及数字文化创意、内容生产 与技术服务。主营业务收入构成为：互联网视频应用产品及服务93.52%，数字创意产品及应用服务 4.87%，算力系统集成及技术服务1.35%，其他业务0.26%。 从恒信东方十大流通股东角度 数据显示，广发基金旗下1只基金位居恒信东方十大流通股东。广发量化多因子混合A（005225）三季 度新进十大流通股东，持有股数251.72万股，占流通股的比例为0.42%。根据测算，今日浮盈赚取约 75.52万元。 广发量化多因子混合A（005225）成立日期2018年3月21日，最新规模36.18亿。今年以来收益42.25%， 同类排名869/8209；近一年收益42.59%，同类排名668/8129；成立以来收益118.33%。 责任编辑：小浪快报 广发量化多因子混合A（005225）基金经理为 ...

11月24日，北大医药涨5.82%，截至发稿，报6.18元/股，成交6692.86万元，换手率1.87%，总市值36.83 亿元。 李育鑫累计任职时间2年34天，现任基金资产总规模37.93亿元，任职期间最佳基金回报81.47%， 任职 期间最差基金回报-4.07%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 广发量化多因子混合A（005225）成立日期2018年3月21日，最新规模36.18亿。今年以来收益42.25%， 同类排名869/8209；近一年收益42.59%，同类排名668/8129；成立以来收益118.33%。 广发量化多因子混合A（005225）基金经理为易威、李育鑫。 截至发稿，易威累计任职时间2年143天，现任基金资产总规模38.18亿元，任职期间最佳基金回报 59.46%， 任职期间最差基金回报-4.07%。 资料显示，北大医药股份有限公司位于重庆市两江新区金开大道90号棕榈泉国际中心B座21楼，成立日 期1993年5月1 ...

11月21日，达意隆跌5.04%，截至发稿，报13.94元/股，成交6675.46万元，换手率2.99%，总市值27.74 亿元。达意隆股价已经连续3天下跌，区间累计跌幅4.05%。 从达意隆十大流通股东角度 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 数据显示，广发基金旗下1只基金位居达意隆十大流通股东。广发量化多因子混合A（005225）三季度 新进十大流通股东，持有股数113.05万股，占流通股的比例为0.72%。根据测算，今日浮亏损失约83.66 万元。连续3天下跌期间浮亏损失70.09万元。 责任编辑：小浪快报 广发量化多因子混合A（005225）成立日期2018年3月21日，最新规模36.18亿。今年以来收益47.06%， 同类排名907/8136；近一年收益48.43%，同类排名655/8056；成立以来收益125.71%。 广发量化多因子混合A（005225）基金经理为易威、李育鑫。 截至发稿，易威累计任职时间2年140天，现任基金资产总规模38.72 ...

11月17日，三元股份跌6.87%，截至发稿，报6.10元/股，成交2917.80万元，换手率0.32%，总市值91.63 亿元。 广发量化多因子混合A（005225）成立日期2018年3月21日，最新规模36.18亿。今年以来收益50.74%， 同类排名882/8213；近一年收益53.45%，同类排名525/8130；成立以来收益131.36%。 广发量化多因子混合A（005225）基金经理为易威、李育鑫。 从三元股份十大流通股东角度 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 数据显示，广发基金旗下1只基金位居三元股份十大流通股东。广发量化多因子混合A（005225）三季 度新进十大流通股东，持有股数429.51万股，占流通股的比例为0.29%。根据测算，今日浮亏损失约 193.28万元。 责任编辑：小浪快报 截至发稿，易威累计任职时间2年136天，现任基金资产总规模38.72亿元，任职期间最佳基金回报 68.97%， 任职期间最差基金回报-1.49%。 李育鑫 ...

广发量化多因子混合A（005225）基金经理为易威、李育鑫。 截至发稿，易威累计任职时间2年133天，现任基金资产总规模38.72亿元，任职期间最佳基金回报 68.08%， 任职期间最差基金回报-1.41%。 李育鑫累计任职时间2年24天，现任基金资产总规模37.93亿元，任职期间最佳基金回报91.28%， 任职 期间最差基金回报1.13%。 11月14日，达意隆涨5.05%，截至发稿，报14.34元/股，成交1.45亿元，换手率6.61%，总市值28.54亿 元。 资料显示，广州达意隆包装机械股份有限公司位于广东省广州市黄埔区云埔一路23号，成立日期1998年 12月18日，上市日期2008年1月30日，公司主营业务涉及液体自动化包装机械的研发、生产和销售;饮 料、日化洗液等液体的代加工。主营业务收入构成为：液体包装机械及自动化设备93.85%，代加工 6.05%，其他0.10%。 从达意隆十大流通股东角度 数据显示，广发基金旗下1只基金位居达意隆十大流通股东。广发量化多因子混合A（005225）三季度 新进十大流通股东，持有股数113.05万股，占流通股的比例为0.72%。根据测算，今日浮盈赚取约78万 ...

Core Viewpoint - North Medical Pharmaceutical Co., Ltd. experienced a stock price increase of 5.09%, reaching 6.81 CNY per share, with a trading volume of 495 million CNY and a turnover rate of 12.58%, resulting in a total market capitalization of 4.059 billion CNY [1] Company Overview - North Medical Pharmaceutical, established on May 18, 1993, and listed on June 16, 1997, is located in Yubei District, Chongqing. The company specializes in the research, production, and sales of chemical drug formulations, pharmaceutical distribution, and medical services [1] - The revenue composition of the company includes: pharmaceuticals 34.69%, formulation drugs 34.34%, medical devices and reagents 30.82%, other (supplementary) 0.13%, and sales of goods and materials 0.03% [1] Shareholder Information - Among the top ten circulating shareholders of North Medical Pharmaceutical, one fund from GF Fund Management, the GF Quantitative Multi-Factor Mixed A (005225), has recently entered the list, holding 2.278 million shares, which accounts for 0.38% of the circulating shares. The estimated floating profit today is approximately 751,700 CNY [2] - The GF Quantitative Multi-Factor Mixed A fund was established on March 21, 2018, with a latest scale of 3.618 billion CNY. Year-to-date returns are 50.46%, ranking 1006 out of 8147 in its category; the one-year return is 51.67%, ranking 569 out of 8056; and since inception, the return is 130.92% [2] - The fund managers, Yi Wei and Li Yuxin, have had varying performance during their tenure, with Yi Wei achieving a best fund return of 68.08% and a worst return of -1.82% over 2 years and 130 days, while Li Yuxin achieved a best return of 95.86% and a worst return of 1.14% over 2 years and 21 days [2]

Group 1 - The core viewpoint of the article highlights the institutional investment landscape in Tianzheng Electric (605066.SH), indicating a significant presence of institutional investors with a total holding of 132 million shares, representing 26.14% of the total share capital [1] - The proportion of institutional holdings increased by 1.54 percentage points compared to the previous quarter, reflecting growing confidence among institutional investors [1] - Among public funds, there was an increase in holdings from one fund, 博道久航混合A, with a holding increase ratio of 0.21% [1] Group 2 - New disclosures from foreign investors included one entity, J.P. Morgan Securities PLC - proprietary funds, indicating a cautious but present interest from foreign institutions [2]